Waters Corporation $WAT Stock Sold by Voya Investment Management LLC

Voya Investment Management LLC trimmed its position in Waters Corporation (NYSE:WAT – Free Report) by 15.9% during the third quarter, HoldingsChannel.com reports. The fund owned 549,919 shares of the medical instruments supplier’s stock after selling 104,048 shares during the quarter. Voya Investment Management LLC’s holdings in Waters were worth $240,943,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in WAT. Global Retirement Partners LLC increased its stake in shares of Waters by 8.0% in the 3rd quarter. Global Retirement Partners LLC now owns 1,265 shares of the medical instruments supplier’s stock valued at $556,000 after purchasing an additional 94 shares during the last quarter. South Dakota Investment Council bought a new stake in shares of Waters during the 3rd quarter worth $2,748,000. Rothschild Investment LLC bought a new stake in shares of Waters during the 3rd quarter worth $128,000. Cibc World Market Inc. lifted its position in shares of Waters by 151.9% during the 3rd quarter. Cibc World Market Inc. now owns 15,327 shares of the medical instruments supplier’s stock worth $6,735,000 after buying an additional 9,242 shares during the last quarter. Finally, Bridges Investment Management Inc. boosted its stake in Waters by 170.6% in the third quarter. Bridges Investment Management Inc. now owns 9,272 shares of the medical instruments supplier’s stock valued at $4,074,000 after buying an additional 5,845 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Down 0.9%

Shares of WAT opened at $449.28 on Wednesday. Waters Corporation has a 52 week low of $282.77 and a 52 week high of $483.33. The stock has a market capitalization of $44.16 billion, a price-to-earnings ratio of 192.82, a PEG ratio of 2.58 and a beta of 1.16. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.28 and a current ratio of 1.89. The stock has a fifty day moving average of $442.24 and a 200-day moving average of $374.83.

Waters (NYSE:WAT – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.00 by $0.10. The company had revenue of $1.77 billion for the quarter, compared to the consensus estimate of $1.75 billion. Waters had a return on equity of 9.91% and a net margin of 1.75%. Waters’s revenue for the quarter was up 120.9% on a year-over-year basis. During the same quarter last year, the business posted $3.40 EPS. As a group, sell-side analysts anticipate that Waters Corporation will post 14.65 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. The Goldman Sachs Group lifted their target price on Waters from $465.00 to $515.00 and gave the company a “buy” rating in a research report on Monday, September 21st. Leerink Partners increased their target price on shares of Waters from $420.00 to $450.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Evercore raised their price target on shares of Waters from $410.00 to $480.00 in a research note on Wednesday, October 7th. UBS Group upgraded shares of Waters from a “neutral” rating to a “buy” rating and raised their price target for the company from $375.00 to $490.00 in a research note on Wednesday, September 9th. Finally, Wells Fargo & Company lifted their price target on shares of Waters from $370.00 to $400.00 and gave the company an “equal weight” rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $475.48.

Get Our Latest Analysis on WAT

About Waters

(Free Report)

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

See Also

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.